[Saliva production in patients with diffuse lung disease]

Area of Science:

• Pulmonology
• Rheumatology
• Immunology

Background:

• Diffuse lung disease (DLD) encompasses various conditions affecting lung tissue.
• Sjögren's syndrome, an autoimmune disorder, can manifest with extraglandular symptoms, including lung involvement.
• Early diagnosis of Sjögren's syndrome in DLD patients is crucial for appropriate management.

Purpose of the Study:

• To investigate the prevalence and clinical significance of Sjögren's syndrome in patients with diffuse lung disease.
• To evaluate the efficacy of the Saxon test as a screening tool for detecting reduced salivary production in this cohort.

Main Methods:

• A prospective clinical study involving 67 patients diagnosed with diffuse lung disease.
• Saliva production was quantitatively assessed using the Saxon test.
• Patients were screened for xerosis (dryness) and subsequently evaluated for Sjögren's syndrome.

Main Results:

• Reduced saliva production was identified in 16.4% of the DLD patients.
• Sjögren's syndrome was diagnosed in 6.0% of the study cohort.
• Lung manifestations associated with Sjögren's syndrome included primary pulmonary lymphoma, bronchiolitis, sarcoidosis, and interstitial pneumonia.

Conclusions:

• Sjögren's syndrome should be considered in the differential diagnosis of patients presenting with diffuse lung disease.
• The Saxon test is an effective and practical screening method for identifying reduced salivary flow in DLD patients.
• Distinguishing between sicca syndrome and Sjögren's syndrome is vital for accurate diagnosis and treatment planning in diffuse lung disease.